# Anti-Oxidant Treatment of Alzheimer's Disease

> **NCT00117403** · PHASE1 · COMPLETED · sponsor: **National Institute on Aging (NIA)** · enrollment: 75 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Vitamin E, Vitamin C, and Alpha-lipoic Acid
- **DRUG:** Coenzyme Q
- **DRUG:** Placebo capsules
- **DRUG:** Placebo wafers

## Key facts

- **NCT ID:** NCT00117403
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2009-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117403, "Anti-Oxidant Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00117403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*